Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

4DMEDICAL LIMITED Share Issue/Capital Change 2021

Jun 27, 2021

64259_rns_2021-06-27_62a657fe-6a15-41c7-8602-a23cda5b10c0.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

4DMEDICAL LIMITED

Date of this announcement

Monday June 28, 2021

The +securities the subject of this notification are:

+Securities issued under an +employee incentive scheme that are subject to a restriction on transfer and are not being quoted on ASX until the restriction ends

Total number of +securities to be issued/transferred

Total number of
ASX +security +securities to be
code Security description issued/transferred Issue date
New class - code OPTION EXPIRING 25-DEC-2024 EX $2.33 66,476 25/06/2021
to be confirmed
New class - code OPTION EXPIRING 25-JUN-2025 EX $1.30 1,346,155 25/06/2021
to be confirmed

Refer to next page for full details of the announcement

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

1 / 8

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Entity and announcement details

1.1 Name of entity

4DMEDICAL LIMITED

We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.

1.2 Registered number type

ACN

Registration number

161684831

1.3 ASX issuer code

4DX

1.4 The announcement is

==> picture [8 x 8] intentionally omitted <==

New announcement

1.5 Date of this announcement

28/6/2021

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

2 / 8

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Issue details

2.1 The +securities the subject of this notification are:

+Securities issued under an +employee incentive scheme that are subject to a restriction on transfer and are not being quoted on ASX until the restriction ends

2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:

==> picture [8 x 8] intentionally omitted <==

does not have an existing ASX security code ("new class")

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

3 / 8

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Part 3C - number and type of +securities the subject of this notification (new class) where issue has not previously been notified to ASX in an Appendix 3B

==> picture [538 x 554] intentionally omitted <==

----- Start of picture text -----

New +securities issued under an +employee incentive scheme
ASX +security code +Security description
New class - code to be confirmed OPTION EXPIRING 25-DEC-2024 EX $2.33
+Security type ISIN code
Options
Date the +securities the subject of this notification were issued
25/6/2021
Will all the +securities issued in this class rank equally in all respects from their issue date?
Yes
Were any of the +securities issued to +key management personnel (KMP) or an +associate?
No
Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under
listing rule 6.1?
Yes
Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being
issued.
A general summary of the plan is set out in the company¿s IPO prospectus which is available at the following URL:
https://investors.4dmedical.com/DownloadFile.axd?file=/Report/ComNews/20200807/02264279.pdf
The Long Term Incentive Plan Rules are available at the following URL:
https://investors.4dmedical.com/DownloadFile.axd?file=/Report/ComNews/20200807/02264299.pdf
Options Details
+Security currency Exercise price Expiry date
AUD - Australian Dollar AUD 2.33000000 25/12/2024
Details of the existing class of +security that will be issued upon exercise or conversion of this new class of
company option
Other
Description
4DX fully paid ordinary shares
----- End of picture text -----

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

4 / 8

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms

The Long Term Incentive Plan Rules are available at the following URL: https://investors.4dmedical.com/DownloadFile.axd?file=/Report/ComNews/20200807/02264299.pdf

Any other information the entity wishes to provide about the +securities the subject of this notification

The grant of options has been made on the following key terms:

¿ The only vesting condition is that the holder of the options must remain employed by 4DMedical (or one of its related entities) for a period of two and a half years from the grant date in order for those options to vest and become exercisable.

¿ Once vested those options remain exercisable by the holder for a period up to 12 months, after which time any unvested or unexercised options will then automatically lapse. ¿ The options are otherwise subject to the rules of the Long Term Incentive Plan.

Issue details

Number of +securities

66,476

New +securities issued under an +employee incentive scheme

==> picture [495 x 32] intentionally omitted <==

----- Start of picture text -----

ASX +security code +Security description
New class - code to be confirmed OPTION EXPIRING 25-JUN-2025 EX $1.30
----- End of picture text -----

+Security type ISIN code
Options
Date the +securities the subject of this notification were issued
25/6/2021

Will all the +securities issued in this class rank equally in all respects from their issue date? Yes

Were any of the +securities issued to +key management personnel (KMP) or an +associate? No

Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under listing rule 6.1? Yes

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

5 / 8

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being issued.

A general summary of the plan is set out in the company¿s IPO prospectus which is available at the following URL: https://investors.4dmedical.com/DownloadFile.axd?file=/Report/ComNews/20200807/02264279.pdf The Long Term Incentive Plan Rules are available at the following URL: https://investors.4dmedical.com/DownloadFile.axd?file=/Report/ComNews/20200807/02264299.pdf

Options Details

+Security currency

AUD - Australian Dollar

Exercise price Expiry date AUD 1.30000000 25/6/2025

Details of the existing class of +security that will be issued upon exercise or conversion of this new class of company option

Other

Description

4DX fully paid ordinary shares

Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms

The Long Term Incentive Plan Rules are available at the following URL: https://investors.4dmedical.com/DownloadFile.axd?file=/Report/ComNews/20200807/02264299.pdf

Any other information the entity wishes to provide about the +securities the subject of this notification

The grant of options has been made on the following key terms:

¿ The only vesting condition is that the holders of the options must remain employed by 4DMedical (or one of its related entities) for a period of three years from the grant date in order for those options to vest and become exercisable. ¿ Once vested those options remain exercisable by the holders for a period up to 12 months, after which time any unvested or unexercised options will then automatically lapse.

¿ The options are otherwise subject to the rules of the Long Term Incentive Plan.

Issue details

Number of +securities

1,346,155

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

6 / 8

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Part 4 - +Securities on issue

Following the issue, conversion or payment up of the +securities the subject of this application, the +securities of the entity will comprise:

(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)

4.1 Quoted +Securities (Total number of each +class of +securities quoted)

Total number of
ASX +security code and description +securities on issue
4DX : ORDINARY FULLY PAID 207,167,466
4.2 Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX)
Total number of
ASX +security code and description +securities on issue
4DXAL : ORDINARY FULLY PAID RESTRICTED 1,736,255
4DXAA : ORDINARY FULLY PAID RESTRICTED 85,536,074
4DXAG : OPTION EXPIRING VAR DATES RESTRICTED EX VAR PRICES 12,770,998
4DXAH : OPTION EXPIRING 24-OCT-2022 EX 71C 2,256,775
4DXAI : OPTION EXPIRING 31-DEC-2024 RESTRICTED EX 40C 2,000,000
4DXAJ : OPTION EXPIRING 15-MAR-2027 EX $1.20 2,133,333
4DXAK : OPTION EXPIRING 07-AUG-2024 EX 73C 1,441,012
4DXAM : OPTION EXPIRING 15-MAR-2025 EX $2.33 14,367
New class - code to be confirmed : OPTION EXPIRING 25-DEC-2024 EX $2.33 66,476
New class - code to be confirmed : OPTION EXPIRING 25-JUN-2025 EX $1.30 1,346,155

4.2 Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX)

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

7 / 8

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities

==> picture [21 x 22] intentionally omitted <==

Part 5 - Other Listing Rule requirements

5.1 Were the +securities issued under an exception in Listing Rule 7.2 and therefore the issue did not need any security holder approval under Listing Rule 7.1? Yes

5.1a Select the number of the applicable exception in Listing Rule 7.2

13

Notification of Issue, Conversion or Payment up of Unquoted E it S iti

8 / 8